PD Dr. Andrej Schmidt to perform live case transmission
of carotid stent surgery utilizing CGuard™
BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its CGuard™ Carotid Embolic Prevention System will be featured in three tracks at the Leipzig Interventional Course (LINC) 2017 to be held January 24th to 27th at the Trade Fair Leipzig, Hall 2 in Leipzig Germany.
On January 24, from 4:30 – 6:00 PM Central European Time, PD Dr. Andrej Schmidt and Dr. Sven Bräunlich from the Department of Angiology, University Hospital Leipzig, Division of Interventional Angiology, Leipzig, Germany will perform a live stent endovascular interventional procedure featuring the CGuard™ EPS Carotid Stent that will be transmitted real time to the congress. PD Dr. Andrej Schmidt is also a member of the LINC Scientific Committee.
The CGuard™ Carotid Embolic Prevention System will be featured at Penumbra, Inc.’s booth (15c).
LINC is a leading global forum for new methods in the field of vascular medicine. LINC brings together medical professionals from different specialties around the world who perform endovascular interventions.
Sessions featuring CGuard™ will include:
What: Clinical results and mechanical properties of a novel double-layered carotid stent
When: January 24: 3:35 – 3:40 PM Central European Time
Where: Speakers’ Corner
What: Early results of a prospective registry of carotid stenting with the new CGuard™
mesh covered stent in real world: The IRON-GUARD registry (L. Capoccia)
When: January 24: 3:45 – 3:50 PM Central European Time
Where: Speakers’ Corner
What: CGuard™ embolic prevention system (EPS) – routine use in carotid revascularisation for
stroke prevention: Accumulating clinical evidence (P. Musialek)
When: January 26: 12:35 – 1:20 PM Central European Time
Where: Room 3 – Technical Forum
“We are excited to have CGuard™ featured so prominently at LINC 2017,” said James Barry, PhD, Chief Executive Officer of InspireMD. “It is an even greater honor to have a professor of Dr. Schmidt’s stature perform a live broadcast of a carotid stent procedure featuring our technology.”
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.
InspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard™), neurovascular, and peripheral artery procedures. InspireMD’s common stock is quoted on the NYSE MKT under the ticker symbol NSPR and certain warrants are quoted on the NYSE MKT under the ticker symbol NSPR.WS.
Chief Financial Officer
Phone: 1-888-776-6804 FREE
Crescendo Communications, LLC
Phone: (212) 671-1021